Victrex plc (LON:VCT - Get Free Report)'s share price traded down 8.4% during mid-day trading on Wednesday . The stock traded as low as GBX 667.62 ($9.07) and last traded at GBX 720 ($9.78). 827,259 shares traded hands during trading, an increase of 97% from the average session volume of 420,250 shares. The stock had previously closed at GBX 786 ($10.68).
Analyst Ratings Changes
Several research analysts have issued reports on the stock. Deutsche Bank Aktiengesellschaft cut shares of Victrex to a "hold" rating and dropped their target price for the stock from GBX 990 ($13.45) to GBX 850 ($11.55) in a report on Tuesday. JPMorgan Chase & Co. lowered their price target on shares of Victrex from GBX 940 ($12.77) to GBX 818 ($11.11) and set a "neutral" rating on the stock in a report on Wednesday.
Read Our Latest Stock Report on VCT
Victrex Stock Up 1.3%
The firm has a market capitalization of £635.05 million, a P/E ratio of 20.68, a PEG ratio of 1.92 and a beta of 0.69. The company has a debt-to-equity ratio of 10.93, a quick ratio of 1.99 and a current ratio of 4.39. The business's fifty day moving average price is GBX 795.78 and its two-hundred day moving average price is GBX 890.75.
Victrex (LON:VCT - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.31) earnings per share for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. Equities analysts expect that Victrex plc will post 73.1078905 earnings per share for the current fiscal year.
Insider Activity at Victrex
In related news, insider David Thomas acquired 1,158 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The stock was purchased at an average cost of GBX 846 ($11.49) per share, with a total value of £9,796.68 ($13,308.90). Also, insider Dame Vivienne Cox acquired 2,747 shares of the firm's stock in a transaction that occurred on Tuesday, July 8th. The stock was bought at an average cost of GBX 721 ($9.79) per share, with a total value of £19,805.87 ($26,906.49). Company insiders own 1.64% of the company's stock.
About Victrex
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
